Skip to Main Content

Paper Details

Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplification.
Cold Spring Harb Mol Case Stud
46
2016
10p, CD274, CUP, Cancer, Chromosome, Chromosome 9p24, Chromosomes 9p, G12S, GATA3, JAK2, KRAS, KRAS G12S mutation, PDL1, PDL1 mRNA, TNBC, TNBC samples, TP53, cancer, cancer of unknown primary, patients, poorly differentiated adenocarcinoma, poorly differentiated soft-tissue sarcoma, sarcoma, triple-negative breast cancer, tumor
Author NameAffiliation
Barbara Hutter
Barbara Hutter
Jan BudcziesInstitute of Pathology, Charite University Hospital
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg University Hospital
Sebastian Uhrig
Daniel H??bschmannInstitute for Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg University Hospital
Daniel H??bschmannInstitute for Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg University Hospital
Stephan Wolf
Peter SchirmacherGermany Institute of Pathology, Heidelberg University Hospital and NCT Heidelberg
Christof von KalleNational Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg University Hospital, Heidelberg Center for Personalized Oncology (HIPO)
Benedikt Brors
Benedikt Brors
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital and NCT Heidelberg, Center for Integrated Diagnostics, Massachusetts General Hospital, Harvard Medical School
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg University Hospital
  • 1 - 14

Datasets

Release 1.2